Education
About Us
Working with TipRanks
Follow Us
InDex Pharmaceuticals Holding AB (DE:1NP1)
:1NP1
1NP1 Stock Chart & Stats
Day’s Range― - ―
52-Week Range€3.47 - €4.25
Previous CloseN/A
Volume0.00
Average Volume (3M)0.00
Market Cap
€308.85M
Enterprise Value€2.79B
Total Cash (Recent Filing)€802.10M
Total Debt (Recent Filing)kr800.00K
Price to Earnings (P/E)0.3
Beta7.15
Next Earnings
Jul 31, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.30
Shares Outstanding78,066,410
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG Ratio0.05
Price to Book (P/B)0.91
Price to Sales (P/S)0.00
P/FCF Ratio-2.37K
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€4.03Price Target Upside1.51% Upside
Rating ConsensusHold
Number of Analyst Covering0
1NP1 FAQ
What was InDex Pharmaceuticals Holding AB’s price range in the past 12 months?
InDex Pharmaceuticals Holding AB lowest stock price was €3.47 and its highest was €4.25 in the past 12 months.
What is InDex Pharmaceuticals Holding AB’s market cap?
InDex Pharmaceuticals Holding AB’s market cap is €308.85M.
When is InDex Pharmaceuticals Holding AB’s upcoming earnings report date?
InDex Pharmaceuticals Holding AB’s upcoming earnings report date is Jul 31, 2025 which is in 10 days.
How were InDex Pharmaceuticals Holding AB’s earnings last quarter?
Currently, no data Available
Is InDex Pharmaceuticals Holding AB overvalued?
According to Wall Street analysts InDex Pharmaceuticals Holding AB’s price is currently Undervalued.
Does InDex Pharmaceuticals Holding AB pay dividends?
InDex Pharmaceuticals Holding AB does not currently pay dividends.
What is InDex Pharmaceuticals Holding AB’s EPS estimate?
InDex Pharmaceuticals Holding AB’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does InDex Pharmaceuticals Holding AB have?
InDex Pharmaceuticals Holding AB has 78,066,410 shares outstanding.
What happened to InDex Pharmaceuticals Holding AB’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of InDex Pharmaceuticals Holding AB?
Currently, no hedge funds are holding shares in DE:1NP1
Company Description
InDex Pharmaceuticals Holding AB
Flerie AB (publ) is a venture capital firm specializing in early-stage investments. It seeks to invest in biotech and pharma companies engaged in drug development and associated tools or applications tackling major medical challenges of our time. The firm seeks to invest in Europe, United States and Israel. Flerie AB (publ) was founded in 2011 and is based in Stockholm, Sweden with additional office in London, United Kingdom.
Technical Analysis
Hansa Biopharma AB
―
BioInvent International AB
―
SynAct Pharma AB
―
Vicore Pharma Holding AB
―
Xspray Pharma AB
―